|
⚲
|
| Parkman Healthcare Partners LLC
✚
|
|
|---|---|
| CRD # | 300701 |
| SEC # | 801-114849 |
| CIK # | 0001777015 |
| AUM | $1.7 B (2026-03-27) |
| Employees | 12 (67% Investors, 0% Brokers) |
| Phone | 203-516-3690 |
| Address | 700 Canal Street Stamford, CT 06902 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Stryker Corp | 50.9 | ||
| Dexcom Inc | 43.3 | ||
| Insulet Corp | 32.9 | ||
| Lilly Eli & Co | 31.8 | ||
| PTC Therapeutics Inc | 29.4 | ||
| Xenon Pharmaceuticals Inc | 28.9 | ||
| Boston Scientific Corp | 28.2 | ||
| CVS Caremark Corp | 27.8 | ||
| Arcus Biosciences Inc | 26.1 | ||
| Livanova PLC | 25.7 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Parkman Venture Partners SPV I LP | [2023-03-27] | 9.2 | 4.1 |
| HF | Parkman HP Master Fund LP | [2019-07-02] | 64.5 | 718.9 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 1,744.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 1,744.0 |
| By Discretionary | ||
| Discretionary | 7 | 1,744.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 1,744.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 1,744.0 | |
| United States Persons | 0.0 | |
| Total | 7 | 1,744.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Parkman Healthcare Partners LLC | 3 | 2 | ||
| Parkman Venture Partners GP LLC | 1 | 1 | ||
| Parkman HP Fund GP LLC | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001777015] | |
| 3 | [0001777015] | |
| 4 | [0001777015] | |
| SC 13G | [0001777015] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Parkman Healthcare Partners LLC | InspireMD Inc | [2025-11-14] |
| Parkman Healthcare Partners LLC | Plus Therapeutics Inc | [2022-02-04] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Martinez Gregory | |
| Parkman Healthcare Partners LLC | |
| Spruce Biosciences Inc |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Tensile Capital Management LP
✚
|
CA | 1.8 |
|
Morgan Creek Capital Management LLC
✚
|
NC | 1.8 |
|
QVT Financial LP
✚
|
NY | 1.8 |
|
Alta Park Capital LP
✚
|
CA | 1.8 |
|
Great Point Partners LLC
✚
|
CT | 1.8 |
|
OFS Capital Management LLC
✚
|
IL | 1.8 |
|
RCF Management LLC
✚
|
CO | 1.8 |
|
Long Path Partners LP
✚
|
CT | 1.7 |
|
Galaxy Digital Capital Management LP
✚
|
NY | 1.7 |
|
Wexford Capital LP
✚
|
FL | 1.7 |